We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
New Hampshire’s Supreme Court ruled private attorneys can continue to represent the state in an investigation into the pharmaceutical industry. Read More
Teva Pharmaceuticals filed a federal lawsuit accusing a former executive of passing trade secrets to rival firm Apotex through her boyfriend, Apotex CEO Jeremy Desai. Read More
The FDA is planning to modernize its recruitment and hiring practices to fill the several hundred vacancies plaguing the agency and attract more scientific talent. Read More
A complaint about ineffective erectile dysfunction drugs led to an FDA inspection of a Texas-based compounder, resulting in a lengthy warning letter from the agency detailing sterility concerns. Read More
Unable to resolve persistent manufacturing problems, New Jersey-based drugmaker Pacira Pharmaceuticals is ending production of its DepoCyt chemotherapy drug and closing the California plant where it is made. Read More
A PET finished dose manufacturer in Ohio was cited by the FDA after investigators witnessed numerous cGMP violations and potential quality problems on a January 2014 site visit. Read More
An FDA-requested report from the National Academies of Sciences, Engineering and Medicine said it is possible to slow the spread of the opioid epidemic without limiting access to properly prescribed painkillers. Read More
Eli Lilly & Co. settled with several generic companies to resolve pending litigation over a unit dose patent for Cialis (tadalafil), delaying potential ANDA competition. Read More